Correlation Between Ikena Oncology and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and SAB Biotherapeutics, you can compare the effects of market volatilities on Ikena Oncology and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and SAB Biotherapeutics.
Diversification Opportunities for Ikena Oncology and SAB Biotherapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ikena and SAB is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Ikena Oncology and SAB Biotherapeutics
Given the investment horizon of 90 days Ikena Oncology is expected to generate 7.37 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Ikena Oncology is 6.12 times less risky than SAB Biotherapeutics. It trades about 0.08 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 275.00 in SAB Biotherapeutics on August 24, 2024 and sell it today you would earn a total of 32.00 from holding SAB Biotherapeutics or generate 11.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. SAB Biotherapeutics
Performance |
| Timeline |
| Ikena Oncology |
| SAB Biotherapeutics |
Ikena Oncology and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and SAB Biotherapeutics
The main advantage of trading using opposite Ikena Oncology and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Ikena Oncology vs. Lyra Therapeutics | Ikena Oncology vs. Hookipa Pharma | Ikena Oncology vs. Cingulate Warrants | Ikena Oncology vs. SAB Biotherapeutics |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |